AI Analysis AI Analysis of CMPS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CMPS to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very red day for Compass Pathways PLC stock price after a -5.51% fall in the Monday trading session
(Updated on Jul 20, 2026)

Sell candidate since Jul 16, 2026 Loss -6.11%

The Compass Pathways PLC stock price fell by -5.51% on the last day (Monday, 20th Jul 2026) from $12.35 to $11.67. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 6.49% from a day low at $11.64 to a day high of $12.39. The price has fallen in 6 of the last 10 days and is down by -9.11% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 6 million shares were bought and sold for approximately $64.94 million.

Given the current short-term trend, the stock is expected to rise 44.88% during the next 3 months and, with a 90% probability hold a price between $16.91 and $23.51 at the end of this 3-month period.

CMPS Signals & Forecast

There are few to no technical positive signals at the moment. The Compass Pathways PLC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $12.85 and $12.84. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -22.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Compass Pathways PLC stock

On the downside, the stock finds support just below today's level from accumulated volume at $10.96 and $9.58. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Compass Pathways PLC finds support just below today's level at $10.96. If this is broken, then the next support from accumulated volume will be at $9.58 and $9.25.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.755 between high and low, or 6.49%. For the last week, the stock has had daily average volatility of 8.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMPS) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Compass Pathways PLC to open at $11.90, and during the day (based on 14 day Average True Range), to move between $11.15 and $12.19, which gives a possible trading interval of +/-$1.04 (+/-9.32%) up or down from last closing price. If Compass Pathways PLC takes out the full calculated possible swing range there will be an estimated 9.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.96 (6.08%) than the resistance at $12.43 (6.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Compass Pathways PLC stock A Buy?

The Compass Pathways PLC stock holds several negative signals and despite the positive trend, we believe Compass Pathways PLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.256 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $11.90 ( 1.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CMPS Performance

Trading levels for CMPS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 12.65 8.43%
R2 12.36 5.95%
R1 12.19 4.43%
Price 11.67
S1 11.61 -0.515%
S2 11.43 -2.04%
S3 11.14 -4.51%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.19 21.59%
R2 12.99 11.31%
R1 12.43 6.51%
Price 11.67
S1 10.96 -6.08%
S2 9.58 -17.91%
S3 9.25 -20.74%

FAQ

What is the symbol for Compass Pathways PLC Stock and on which exchange is it traded?
The symbol for Compass Pathways PLC is CMPS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Compass Pathways PLC Stock?
The Compass Pathways PLC stock holds several negative signals and despite the positive trend, we believe Compass Pathways PLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Compass Pathways PLC Stock?
Compass Pathways PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Compass Pathways PLC Stock.

What's the current price of Compass Pathways PLC Stock?
As of the end of day on the Jul 20, 2026, the price of an Compass Pathways PLC (CMPS) share was $11.67.

What is the 52-week high and low for Compass Pathways PLC Stock?
The 52-week high for Compass Pathways PLC Stock is $15.40 and the 52-week low is $3.92.

What is the market capitalization of Compass Pathways PLC Stock?
As of the Jul 20, 2026, the market capitalization of Compass Pathways PLC is 1.121B.

When is the next earnings date for Compass Pathways PLC?
The upcoming earnings date for Compass Pathways PLC is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT COMPASS PATHWAYS PLC
Compass Pathways
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in Augu...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
NMRK
$15.02
3.26% Jun 24
JLL
$299.78
8.73% Jun 24
CAG
$13.43
9.20% Jun 23
CBRE
$133.21
4.13% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE